cis Expression of the F12 human immunodeficiency virus (HIV) nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain:: Involvement of both Env gp41 and CD4 intracytoplasmic tails

被引:28
作者
Olivetta, E
Pugliese, K
Bona, R
D'Aloja, P
Ferrantelli, F
Santarcangelo, AC
Mattia, G
Verani, P
Federico, M
机构
[1] Ist Super Sanita, Virol Lab, I-00161 Rome, Italy
[2] Ist Super Sanita, Lab Clin Biochem, I-00161 Rome, Italy
关键词
D O I
10.1128/JVI.74.1.483-492.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
F12 human immunodeficiency virus type 1 (HIV-1) nef is a naturally occurring nef mutant cloned from the provirus of a nonproductive, nondefective, and interfering HIV-1 variant (F12-HIV). We have already shown that cells stably transfected with a vector expressing the F12-HIV nef allele do not downregulate CD4 receptors and, more peculiarly, become resistant to the replication of wild type (wt) HIV. In order to investigate the mechanism of action of such an HIV inhibition, the F12-HIV nef gene was expressed in the context of the NL4-3 HIV-1 infectious molecular clone by replacing the wt nef gene (NL4-3/chi). Through this experimental approach we established the following. First, NL4-3/chi and nef-defective (Delta nef) NL4-3 viral particles behave very similarly in terms of viral entry and HIV protein production during the first replicative cycle. Second, no viral particles were produced from cells infected with NL4-3/chi virions, whatever the multiplicity of infection used. The viral inhibition apparently occurs at level of viral assembling and/or release. Third, this block could not be relieved by in-trans expression of wt nef. Finally, NL4-3/chi reverts to a producer HIV strain when F12-HIV Nef is deprived of its myristoyl residue. Through a CD4 downregulation competition assay, we demonstrated that F12-HIV Nef protein potently inhibits the CD4 downregulatiom induced by wt Nef. Moreover, we observed a redistribution of CD4 receptors at the cell margin induced by F12-HIV Nef. These observations strongly suggest that F12-HIV Nef maintains the ability to interact with the intracytoplasmic tail of the CD4 receptor molecule. Remarkably, we distinguished the intracytoplasmic tails of Fm gp41 and CD4 as, respectively, viral and cellular targets of the F12-HIV Nef-induced viral retention. For the first time, the inhibition of the viral life cycle by means of in-cis expression of a Nef mutant is here reported. Delineation of the F12-HIV Nef mechanism of action may offer additional approaches to interference with the propagation of HIV infection.
引用
收藏
页码:483 / 492
页数:10
相关论文
共 55 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   NEF INDUCES CD4 ENDOCYTOSIS - REQUIREMENT FOR A CRITICAL DILEUCINE MOTIF IN THE MEMBRANE-PROXIMAL CD4 CYTOPLASMIC DOMAIN [J].
AIKEN, C ;
KONNER, J ;
LANDAU, NR ;
LENBURG, ME ;
TRONO, D .
CELL, 1994, 76 (05) :853-864
[3]   NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS [J].
AIKEN, C ;
TRONO, D .
JOURNAL OF VIROLOGY, 1995, 69 (08) :5048-5056
[4]   Human immunodeficiency virus (HIV)-resistant CD4(+) UT-7 megakaryocytic human cell line becomes highly HIV-1 and HIV-2 susceptible upon CXCR4 transfection: Induction of cell differentiation by HIV-1 infection [J].
Baiocchi, M ;
Olivetta, E ;
Chelucci, C ;
Santarcangelo, AC ;
Bona, R ;
dAloja, P ;
Testa, U ;
Komatsu, N ;
Verani, P ;
Federico, M .
BLOOD, 1997, 89 (08) :2670-2678
[5]   The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase [J].
Baur, AS ;
Sass, G ;
Laffert, B ;
Willbold, D ;
ChengMayer, C ;
Peterlin, BM .
IMMUNITY, 1997, 6 (03) :283-291
[6]   Aberrant, noninfectious HIV-1 particles are released by chronically infected human T cells transduced with a retroviral vector expressing an interfering HIV-1 variant [J].
Bona, R ;
dAloja, P ;
Olivetta, E ;
Modesti, A ;
Modica, A ;
Geraci, A ;
Ferrari, G ;
Verani, P ;
Federico, M .
GENE THERAPY, 1997, 4 (10) :1085-1092
[7]   INCORPORATION OF 12-METHOXYDODECANOATE INTO THE HUMAN IMMUNODEFICIENCY VIRUS-1 GAG POLYPROTEIN PRECURSOR INHIBITS ITS PROTEOLYTIC PROCESSING AND VIRUS PRODUCTION IN A CHRONICALLY INFECTED HUMAN LYMPHOID-CELL LINE [J].
BRYANT, ML ;
RATNER, L ;
DURONIO, RJ ;
KISHORE, NS ;
DEVADAS, B ;
ADAMS, SP ;
GORDON, JI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2055-2059
[8]   The non-producer phenotype of the human immunodeficiency virus type 1 provirus F12/HIV-1 is the result of multiple genetic variations [J].
Carlini, F ;
Nicolini, A ;
dAloja, P ;
Federico, M ;
Verani, P .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :2009-2013
[9]  
Carlini F., 1992, J VIRAL DIS, V1, P40
[10]   IN-VITRO HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION OF PURIFIED HEMATOPOIETIC PROGENITORS IN SINGLE-CELL CULTURE [J].
CHELUCCI, C ;
HASSAN, HJ ;
LOCARDI, C ;
BULGARINI, D ;
PELOSI, E ;
MARIANI, G ;
TESTA, U ;
FEDERICO, M ;
VALTIERI, M ;
PESCHLE, C .
BLOOD, 1995, 85 (05) :1181-1187